Figure 2
Distribution of evidence level for treatment choice and clinical trials reported by curation systems. (A) The pie chart shows the distribution of levels of the curated therapeutic information curated by WfG. Green; approved for the said cancer type (evidence level 1), orange; approved for other cancer type (evidence level II), blue; information of clinical trials in any countries (level III). (B) The pie chart shows the distribution of levels of the curated therapeutic information curated by OKR. Green; approved for the said cancer type (level 1), orange; approved for other cancer type (evidence level II), blue; information of clinical trials in Asian countries (Japan, Korea, China, Taiwan, Singapore) (level III). (C) The pie chart shows the distribution of levels of the curated therapeutic information curated by QCII. Green; approved for the said cancer type (level 1), orange; approved for other cancer type (level II), blue; information of clinical trials in Japan (level III). (D) Venn diagram shows the commonality of clinically informative genetic variants (across all evidence levels, see Supplementary Table 1) between curation systems.
